Loading clinical trials...
Loading clinical trials...
Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP): a Single-arm, Multi-centre, Observational Study
Conditions
Interventions
Avatrombopag
Locations
1
China
Qilu Hospital, Shandong University
Jinan, Shandong, China
Start Date
March 1, 2021
Primary Completion Date
October 1, 2021
Completion Date
March 1, 2022
Last Updated
July 2, 2021
NCT05070845
NCT07039422
NCT06888960
NCT06594146
NCT07421167
NCT07083739
Lead Sponsor
Shandong University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions